Exhibitors Search
MEPSGEN

Booth no.
A22
Exhibition | NextRegenX |
---|---|
Country | Korea, South |
Address | 12 Beobwon-ro 11-gil, Songpa-gu, Seoul, Republic of Korea |
Tel (Rep.) | 02-401-4370 |
Website | http://mepsgen.com |
Company Introduction
MEPSGEN is a biotechnology company advancing drug discovery and development through Microphysiological Systems (MPS), such as Organ-on-a-Chip, and nanoparticle-based drug delivery systems (DDS) powered by microfluidic technology. Our MPS platform enables the modeling of human physiology and pathology at the tissue level, providing greater predictive accuracy than animal models and enabling the early detection of potential drug failures to improve success rates. Our DDS platform is designed to enhance the efficiency and safety of delivering hard-to-target therapeutic modalities such as mRNA and ASOs.
By integrating MPS and DDS, we provide a comprehensive, high-performance solution that enables rapid candidate and formulation screening, optimizes delivery efficiency, and accelerates clinical translation. Through this synergistic platform, MEPSGEN is pioneering a paradigm shift in drug discovery as a trusted global partner delivering innovative therapeutic solutions.
By integrating MPS and DDS, we provide a comprehensive, high-performance solution that enables rapid candidate and formulation screening, optimizes delivery efficiency, and accelerates clinical translation. Through this synergistic platform, MEPSGEN is pioneering a paradigm shift in drug discovery as a trusted global partner delivering innovative therapeutic solutions.
Promotional video
Exhibit Item
(1) MEPS-TBC-WL, (2) MEPS-TBC-CH, (3) MEPS-ORD, (4) ProMEPS™, (5) NanoCalibur™ Lab
Exhibit Item Images
-
Product Name : MEPS-TBC-WL2D-3D hybrid tissue-to-tissue barrier or interface modeling - Compatible with physiological shear flow in the top channel - Multiple cells and matrices loaded to recapitulate complex 3D human tissue architecture - Direct solution loading by dripping into the bottom open well - Applicable to ProMEPS™
-
Product Name : MEPS-TBC-CH2D-2D hybrid tissue-to-tissue barrier or interface modeling - Compatible with physiological shear flow in both channels
-
Product Name : MEPS-ORD-Vascularized 3D microtissues constructed by 2D-3D hybrid co-culture - Recapitulating 3D vascular architecture and functions - Applicable to ProMEPS™
-
Product Name : ProMEPS™Automated robotic operation in ProMEPS™ enables highly reproducible modeling and enhances user convenience, ensuring robust and cost-effective research.
-
Product Name : NanoCalibur™ LabNanoCalibur™ provides unprecedented solutions with advanced microfluidic technologies to formulate various types of nanoparticles (NPs) with precisely defined properties and tunable scalability.
Exhibit Description
MEPSGEN’s Microphysiological Systems (MPS) platform includes the “MEPS-X Series,” a 3D organ-on-a-chip product line, and the automated MPS modeling system “ProMEPS™.” In the Drug Delivery System (DDS) platform, MEPSGEN offers the automated nanoparticle synthesis systems “NanoCalibur™ Lab” and “NanoCalibur™ GMP.”
Co-Exhibitor or
Partner’s Information
Company Name | Country |
---|---|